PHARMACOKINETICS OF SINGLE VERSUS DOUBLE-DOSE DOLUTEGRAVIR AFTER SWITCHING FROM A FAILING EFAVIRENZ-BASED REGIMEN. Griesel R, Banda CG, Zhao Y, Omar Z, et al. J Acquir Immune Defic Syndr 2024 Feb 15. doi: 10.1097/QAI.0000000000003402.

Read + Share

Amedeo Smart

Independent Medical Education

Griesel R, Banda CG, Zhao Y, Omar Z, et al. PHARMACOKINETICS OF SINGLE VERSUS DOUBLE-DOSE DOLUTEGRAVIR AFTER SWITCHING FROM A FAILING EFAVIRENZ-BASED REGIMEN. J Acquir Immune Defic Syndr 2024 Feb 15. doi: 10.1097/QAI.0000000000003402.
PMID: 38372621